Carla M. Marco

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Sarcopenia in Patients With Cancer and Its Association With Chemotherapy-Induced Peripheral Neurotoxicity.

Sarcopenia in Patients With Cancer and Its Association With Chemotherapy-Induced Peripheral Neurotoxicity.

Journal: Neurology

Published: May 05, 2026

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.

Journal: Brain pathology (Zurich, Switzerland)

Published: August 12, 2025

Posterior Reversible Encephalopathy Syndrome as a Complication of Essential Thrombocythemia: A Case Report and Literature Review.

Posterior Reversible Encephalopathy Syndrome as a Complication of Essential Thrombocythemia: A Case Report and Literature Review.

Journal: Cureus

Published: April 18, 2025

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases.

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 16, 2025

SYNE1 Deficiency Manifesting Primarily With Motor Neuron Disease.

SYNE1 Deficiency Manifesting Primarily With Motor Neuron Disease.

Journal: Neurology. Genetics

Published: January 17, 2025

Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen.

Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen.

Journal: International journal of molecular sciences

Published: February 20, 2024

Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug.

Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug.

Journal: European journal of neurology

Published: February 20, 2024

Comment on: Brentuximab vedotin-related neuropathy in a patient with Gilbert syndrome: Do mutations of UGT1A1 gene affect brentuximab toxicity?

Comment on: Brentuximab vedotin-related neuropathy in a patient with Gilbert syndrome: Do mutations of UGT1A1 gene affect brentuximab toxicity?

Journal: Pediatric blood & cancer

Published: June 11, 2023

Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series.

Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series.

Journal: Journal of clinical medicine

Published: October 14, 2022

Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity.

Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity.

Journal: Journal of neurology

Published: August 13, 2022

Nusinersen in adult patients with 5q spinal muscular atrophy: A multicenter observational cohorts' study.

Nusinersen in adult patients with 5q spinal muscular atrophy: A multicenter observational cohorts' study.

Journal: European journal of neurology

Published: May 04, 2022

Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy.

Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy.

Journal: European journal of neurology

Published: April 29, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026